PRAX
Praxis Precision Medicines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.83B
P/E Ratio
—
EPS
$-13.47
Beta
2.97
52W High
$356.00
52W Low
$28.79
50-Day MA
$314.46
200-Day MA
$182.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $7.46M |
| Gross Profit (TTM) | $-267.12M |
| EBITDA | $-326.06M |
| Operating Margin | 0.00% |
| Return on Equity | -45.80% |
| Return on Assets | -28.70% |
| Revenue/Share (TTM) | $0.35 |
| Book Value | $34.85 |
| Price-to-Book | 10.03 |
| Price-to-Sales (TTM) | 953.14 |
| EV/Revenue | 1215.61 |
| EV/EBITDA | -6.86 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1349.00% |
| Shares Outstanding | $27.85M |
| Float | $25.78M |
| % Insiders | 0.40% |
| % Institutions | 107.09% |
Historical Volatility
HV 10-Day
88.60%
HV 20-Day
72.29%
HV 30-Day
64.06%
HV 60-Day
55.24%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($629.24 target)
2
Strong Buy12
Buy1
Hold1
SellData last updated: 4/14/2026